What is LOPJLB’s current signal on IMA?

LOPJLB’s latest quantitative signal on ImageneBio Inc (IMA) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is IMA in?

ImageneBio Inc (IMA) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does ImageneBio Inc (IMA) do?

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was forme…

Where is ImageneBio Inc based / listed?

ImageneBio Inc is based in US, listed on NASDAQ.

ImageneBio Inc (IMA)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$4.24-0.47%Close

SELLCRISIS · day 2

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $48M
Beta: 0.74
P/E (TTM): -0.88

Short % float: 0.44%
Days to cover: 1.9
SI change: -5.0%

1W: -7.83%
1M: -15.37%

vs SPY 1W: -8.99%
vs SPY 1M: -18.36%

Industry peers

FMP comparable companies · ranked by market cap

STTKSELLShattuck Labs, Inc.$511MCRISISQ 5$5.66+5.48%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news